Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Nicole Hadas | F | 51 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | 12 years |
| Gregory Madison | M | 57 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 17 years |
| Michael Tarnok | M | 69 | 9 years | |
| James Oliviero | M | 48 | 12 years | |
| John Butler | M | 59 |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | 5 years |
| Karen L. Tubridy | M | 61 |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | 2 years |
| Scott A. Holmes | M | 50 | 3 years | |
| Michael Rogers | M | 64 | 2 years | |
| Sanj Patel | M | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 11 years |
| Jodie Morrison | F | 48 | 2 years | |
| Lorenzo M. Tallarigo | M | 74 | 6 years | |
| Amy Sullivan | F | 54 | 4 years | |
| Jean S. K. Lee | M | - |
University of Massachusetts
| 4 years |
| Jack Kaye | M | 80 | 10 years | |
| Mark Enyedy | M | 60 | 1 years | |
| Brian Schiller | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 10 years |
| Linda Bain | F | 53 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 years |
| Steven Burke | M | 63 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Julie Feder | F | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Bryan Yoon | M | 46 | 4 years | |
| Brian Adams | M | 50 | 4 years | |
| Michael Halpin | M | 62 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| Gloria Matthews | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 6 years |
| Ronald Bentsur | M | 58 | 6 years | |
| Peter T. Traynor | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| John Neylan | M | 70 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 years |
| Richard Gregory | M | 66 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
University of Massachusetts
| 15 years |
| Kevin Cameron | M | 64 | 11 years | |
| Ralph Victor Whitworth | M | 68 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Andy Bartlett | M | - |
University of Massachusetts
| 9 years |
| Joseph Feczko | M | 75 | 6 years | |
| Richard F. Syron | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Alan Smith | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 22 years |
| Henry E. Blair | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 26 years |
| Glenn Sblendorio | M | 68 | 9 years | |
| Cornelius McGillicuddy | M | 83 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Wyche Fowler | M | 83 | 10 years | |
| Panayotis Sparaggis | M | - |
University of Massachusetts
| 5 years |
| Klaus Veitinger | M | 62 | 4 years | |
| Wayne Boulais | M | 60 |
University of Massachusetts
| 7 years |
| Brian J. Krol | M | - |
University of Massachusetts
| 7 years |
| Marc Beer | M | 59 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 4 years |
| Luca Benatti | M | 63 | 9 years | |
| Louis J. Arcudi | M | 63 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 5 years |
| Steven Gilman | M | 71 | 2 years | |
| Michael Heffernan | M | 59 | 2 years | |
| Lora L. Pike | F | - | - | |
| Srini Akkaraju Akkaraju | M | 56 | 11 years | |
| Steven J. Burakoff | M | 81 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Sau Lai Ng | M | 57 |
University of Massachusetts
| 4 years |
| Angie Cotterman | F | - |
Southern New Hampshire University
| 4 years |
| Daniel Ngai | M | - |
University of Massachusetts
| 4 years |
| Mike Trudel | M | - |
University of Massachusetts
| 4 years |
| Jordan Tuchek | M | - |
Southern New Hampshire University
| 2 years |
| Eric Keisman | M | - |
University of Massachusetts
| 4 years |
| Brett Jenks | M | - |
University of Massachusetts
| 3 years |
| Dan E. Feder | M | - |
University of Massachusetts
| 4 years |
| James Spalding | M | 57 |
University of Massachusetts
| 4 years |
| Kevin McNally | M | 55 |
University of Massachusetts
| 4 years |
| Cassidy Huckins | F | - |
Southern New Hampshire University
| 4 years |
| Tracey Lodie | M | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 14 years |
| Emma Stewart | F | - |
Southern New Hampshire University
| 4 years |
| Michael Higgins | M | 61 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 6 years |
| Edward Eccles | M | - |
University of Massachusetts
| 4 years |
| Sue Salvemini | F | - |
University of Massachusetts
| 4 years |
| Paula Drake | F | - |
University of Massachusetts
| - |
| Shawna Ferguson | F | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 12 years |
| Svetlana Yuryevna Barmina | F | 56 |
University of Massachusetts
| 4 years |
| Mitchell Boyarsky | M | - |
University of Massachusetts
| 4 years |
| Peter Kawa | M | - |
University of Massachusetts
| 4 years |
| Aaron von Staats | M | 58 |
University of Massachusetts
| 4 years |
| Rajeev Bhalla | M | 61 |
University of Massachusetts
| 4 years |
| John Gerald Fitzgerald | M | 60 |
University of Massachusetts
| 4 years |
| Dean J. Breda | M | - |
University of Massachusetts
| 4 years |
| Peter Jay Kirschenbaum | M | - |
University of Massachusetts
| 4 years |
| Sean Nelen | M | - |
University of Massachusetts
| 3 years |
| Allen Fuqua | M | - |
University of Massachusetts
| 2 years |
| John Langton Sennott | M | 58 |
University of Massachusetts
| 4 years |
| Jason Robert Lilly | M | - |
University of Massachusetts
| 4 years |
| Gil Penchina | M | - |
University of Massachusetts
| 4 years |
| John Schwartz | M | - |
University of Massachusetts
| 4 years |
| Mark M. Andrew | M | - |
University of Massachusetts
| 4 years |
| Michael P. Cloherty | M | - |
University of Massachusetts
| 4 years |
| Dave Kelly | M | - |
University of Massachusetts
| 4 years |
| Maggie M. Burke | F | - |
University of Massachusetts
| 4 years |
| James Lampert | M | - |
University of Massachusetts
| 4 years |
| Jim Miller | M | - |
University of Massachusetts
| 4 years |
| Chuck Garabedian | M | - |
University of Massachusetts
| 4 years |
| Güçlü Toker | M | 62 |
University of Massachusetts
| 4 years |
| Marcin Jan Szumowski | M | - |
University of Massachusetts
| 4 years |
| Jennifer T. Bouthillier | F | - |
University of Massachusetts
| 4 years |
| Harsh Pati Singhania | M | 61 |
University of Massachusetts
| 4 years |
| Michael J. Mullen | M | - |
University of Massachusetts
| 4 years |
| Stephen James Klaus | M | - |
University of Massachusetts
| 6 years |
| Andy Dion | M | - |
University of Massachusetts
| 5 years |
| Alex Yelensky | M | - |
University of Massachusetts
| 4 years |
| Michael J. Hickey | M | - |
University of Massachusetts
| 4 years |
| Barbara Vanderwilden | F | - |
University of Massachusetts
| 4 years |
| Jen Yousif | F | - |
Southern New Hampshire University
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Daniel Paul Regan
- Personal Network